KATHERINE RAINES: Open Payments
NPI 1588693634 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 30 payments from 6 companies in 2025. Trend: 2023 $341 · 2024 $654 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $322 |
| E.R. Squibb & Sons, L.L.C. | 9 | $254 |
| Axsome Therapeutics, Inc. | 2 | $220 |
| Alkermes, Inc. | 9 | $219 |
| Medtronic, Inc. | 1 | $93 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: COBENFY, Auvelity, UZEDY, AUSTEDO XR, LYBALVI, INTELLIS ADAPTIVESTIM, ARISTADA, ABILIFY MAINTENA.
Industry payments across MS — which companies pay providers there.
